Heterogeneous expression of E-cadherin and p53 in prostate cancer: Clinical implications

Modern Pathology

Volumn 11, Issue 3, 1998, Pages 276-281

  Ruijter, Emiel ^a   Van De Kaa, Christina ^a   Aalders, Tilly ^a   Ruiter, Dirk ^a   Miller, Gary ^b   Debruyne, Frans ^a   Schalken, Jack ^a   Schroder F H ^c   Beeker, C G M ^c   Blijenberg, B G ^c   Boeken Kruger, A E ^c   Eman, I ^c   Hoedemaeker, R F ^c   Kirkels, W J ^c   Kranse, R ^c   Van Der Kwast, Th H ^c   Noordzij, M A ^c   Van De Poel, H J A ^c   Romijn, J C ^c   Van Steenbrugge, G J ^c   Trapman, J ^c   Verkaik, N S ^c   Bussemakers, M J G ^c   Hessels, D ^c   Oosterhof, G O N ^c   Ruijter, T E G ^c   Schalken, J A ^c   Thomas, C M G ^c   Witjes, J A ^c   Ylikoski, A ^c   Lovgren T ^c   Lovgren J ^c   Pettersson, K ^c   Piironen, T ^c   Mansikka Savolainen, S ^c   Ahlgren, G ^c   Beeker, C ^c   Bjartell, A ^c   Bjork T ^c   Lilja, H ^c   Lundwall, A ^c   Abrahamsson, P A ^c   Bratt, O ^c   Colleen, S ^c   Elfring, P ^c   Frederiksen, H ^c   Martensson S ^c   Hamdy, F C ^c   Leung, H Y ^c   Neal, D E ^c   Robson, C N ^c   more..

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF COLORADO   (United States)

^c NONE

Author keywords

E cadherin; Heterogeneity; p53; Prostate biopsy; Prostatectomy

Indexed keywords

PROTEIN P53; UVOMORULIN;

AGED; ARTICLE; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; PROTEIN EXPRESSION;

BIOPSY; CADHERINS; GENES, P53; GENETIC HETEROGENEITY; HUMANS; IMMUNOHISTOCHEMISTRY; LABORATORY TECHNIQUES AND PROCEDURES; MALE; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031914109     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Isaacs JT. Molecular markers for prostate cancer metastasis: developing diagnostic methods for predicting the aggressiveness of prostate cancer. Am J Pathol 1997;150:1511-21.
2. Liotta LA, Stetler-Stevenson WG. Principles of molecular cell biology of cancer: cancer metastasis. In: De Vita VT Jr, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. Philadelphia: Lippincott; 1993. p. 134-49.
3. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 1991;113:173-85.
4. Umbas R, Isaacs WB, Bringuier PP, Schaafsma HE, Karthaus HFM, Oosterhof GON, et al. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res 1994;54:3929-33.
5. Visakorpi T, Kalliniemi OP, Heikkinen A, Koivula T, Isola J. Small subgroups of aggressive, highly proliferative prostatic adenocarcinomas defined by p53 accumulation. J Natl Cancer Inst 1992;84:883-7.
6. Finlay CA, Hinds PW, Tan TH, Eliyahu D, Oren M, Levine AJ. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol Cell Biol 1988;8:531-9.
7. Ruijter TEG, Miller GJ, Aalders TW, van de Kaa CA, Schalken JA, Debruyne FMJ, et al. Microwave-stimulated fixation of entire prostatectomy specimens. J Pathol 1997;183:364-75.
8. Ruijter TEG, van de Kaa CA, Schalken JA, Debruyne FMJ, Ruiter DJ. Histological grade heterogeneity in multifocal prostate cancer: biological and clinical implications. J Pathol 1996;180:295-9.
9. Gleason DF. Histologic grading and clinical staging of prostate carcinoma. In: Tannenbaum M, editor. Urological pathology: the prostate. Philadelphia: Lea & Febiger; 1971. p. 171-98.
10. Schröder FH, Hermanek P, Dennis L, Fair WR, Gospodarowicz MK, Pavone-Macaluso M. The TNM classification for prostate cancer. Prostate 1992;4(Suppl):129-38.
11. Cheng L, Nagabhushan M, Pretlow TP, Amini SB, Pretlow TG. Expression of E-cadherin in primary and metastatic prostate cancer. Am J Pathol 1996;148:1375-80.
12. Mirchandani D, Zheng J, Miller GJ, Ghosh AK, Shibata DK, Cote RJ, et al. Heterogeneity in intratumor distribution of p53 mutations in human prostate cancer. Am J Pathol 1995; 147:92-101.
13. Greene DR, Taylor SR, Wheeler TM, Scardino PT. DNA ploidy by image analysis of individual foci of prostate cancer: a preliminary report. Cancer Res 1991;51:4084-9.
14. Sakr WA, Macosca JA, Benson P, Grignon DJ, Wolman SR, Pontes JE, et al. Allelic loss in locally metastatic, multi-sampled prostate cancer. Cancer Res 1994;54:3273-7.
15. Hodge KK, McNeal JE , Terris MD, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989;142:71-75.